CureVac's unique vaccine properties may be key in delivering mRNA vaccines to developing nations
CureVac’s unique vaccine properties may be key in delivering mRNA vaccines to developing nations By Globaldata Healthcare 28 Apr 2021 (Last Updated May 4th, 2021 15:48) The rapid development and distribution of highly efficacious messenger ribonucleic acid (mRNA) vaccines has been regarded as a great success, especially during the ongoing pandemic. As COVID-19 cases continue to soar in some countries, demand for Pfizer and Moderna’s vaccines is fast exceeding production capabilities. Credit: fernando zhiminaicela from Pix...
Source: clinicaltrialsarena.com